Curt Hartman, the company’s vice president and CFO, stepped into the position of interim CEO last week. His target bonus for the year also increased to $750,000. Payment was prorated based on his time as CEO. The company has begun a search for Mr. MacMillan’s permanent replacement and will consider candidates both internally and externally, according to the report.
Related Articles on Orthopedic Devices:
Zimmer & ISTO Technologies Announces Phase III Clinical Study
SI-BONE Receives Patent for Broad Method Claims
Titan Spine Receives Two Patents
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.